august, 2016
30aug6:00 pm8:00 pmPre-Clinical Development of a Humanized Anti-CD47 Antibody
Event Details
EPPIC GLOBAL Presents Entrepreneur Spotlight Pre-Clinical Development of a Humanized Anti-CD47 Antibody Speaker: Ravi Majeti MD, PhD Dr. Majeti is co-founder of \'Forty Seven, Inc.\' Ravi Majeti MD, PhD Associate Professor of Medicine, Division of Hematology Cancer
more
Event Details
EPPIC GLOBAL Presents
Entrepreneur Spotlight
Pre-Clinical Development of a Humanized Anti-CD47 Antibody
Speaker: Ravi Majeti MD, PhD
Dr. Majeti is co-founder of \’Forty Seven, Inc.\’
Ravi Majeti MD, PhD
Associate Professor of Medicine, Division of Hematology
Cancer Institute
Institute for Stem Cell Biology and Regenerative Medicine
Dr. Ravi Majeti\’s illustrious bio can be found at:
https://med.stanford.edu/profiles/majetilab/ravindra-majeti/
When: Tuesday, Aug 30, 2016
6pm – 7pm Networking mixer
7pm – 8:30pm Spotlight Speaker Presentation followed by Q&A
Where: Offices of Shepherd Mullin, 379 Lytton Ave, Palo Alto
Registration is complimentary. Please use this link to register at the earliest and reserve your spot!
https://www.123signup.com/register?id=nzhgh
Time
(Tuesday) 6:00 pm - 8:00 pm